CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
about
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studiesTerpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systemsCannabinoids in experimental stroke: a systematic review and meta-analysis.The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRαSelf-administration of the anandamide transport inhibitor AM404 by squirrel monkeysInhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.
P2860
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
@en
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
@nl
type
label
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
@en
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
@nl
prefLabel
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
@en
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
@nl
P2860
P1476
CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).
@en
P2093
P2860
P304
P356
10.1111/J.1365-2710.2011.01284.X
P577
2011-07-11T00:00:00Z